NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

NeoGenomics Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on NeoGenomics (NEO), CG Oncology, Inc. (CGON) and Icon (ICLR). NeoG...

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), CG Oncology, Inc. (CGON) and Icon (ICLR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NeoGenomics (NEO) and Wave Life Sciences (WVE) with ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF) and NeoGenomics (NEO) ...

Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), NeoGenomics (NEO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT), Neogen (NEOG) and Community Healt...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Neogen (NEOG) and Community Health (CYH)

Stranger Holdings ( ($GB:NEO) ) has shared an announcement. Neo Energy Metals has called its annual general meeting for 18 May 2026 in London and h...

Neo Energy Metals sets AGM and highlights progress at South African uranium-gold projects

NeoVolta ( ($NEOV) ) has issued an announcement. On April 15, 2026, NeoVolta Power, NeoVolta and Can Current Corporation amended and restated the o...

Current Quarter	$-0.05	Next Quarter	$-0.04
Current Year	$-0.17	Next Year	$-0.02
QoQ Growth	+20.0%	YoY Growth	+88.2%
3Y EPS CAGR	+10.2%	Target Price	$14.06
Consensus	Buy	Upside	+48.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NEO	$9.44	+1.94%	2.26M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NEO	$9.44	+1.9%	2.26M
3
4
5
6

NEO

NEO

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get NeoGenomics Inc. Data in Excel

Get NeoGenomics Inc. Data in Excel